ADAPTIR Modular Protein Therapeutic Platform

Name
Pre-clinical
Phase 1
Phase 2
Phase 3
 
 
 
Otlertuzumab
Pre-clinical Phase 1 Phase 2 Phase 3
APVO414
Pre-clinical Phase 1 Phase 2 Phase 3
APVO436
Pre-clinical Phase 1 Phase 2 Phase 3
ALG.APV-527
Pre-clinical Phase 1 Phase 2 Phase 3
APVO210
Pre-clinical Phase 1 Phase 2 Phase 3
ROR1 Candidate
Pre-clinical Phase 1 Phase 2 Phase 3
Multiple ADAPTIR Candidates
Pre-clinical Phase 1 Phase 2 Phase 3